Aducanumab targets the underlying cause of Alzheimer's, the most common form of dementia, rather than its symptoms.
Charities have welcomed the news of a new therapy for the condition. BBC News
See also:
Tuesday, 8 June 2021
US approves first new Alzheimer's drug in 20 years
US approves first new Alzheimer's drug in 20 years The first new treatment for Alzheimer's disease for nearly 20 years has been approved by regulators in the United States, paving the way for its use in the UK.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment